Foundation
MicroDysis is built on long-term work in microfluidic system design and microscale control of fluid behavior.
This foundation integrates engineering, microfabrication, and system design for biological applications.
Joseph Zhili Huang, Ph.D.
FOUNDER
Joseph Huang is a biomedical engineer, inventor, and entrepreneur with over 40 years of experience in biomedical devices and microfluidic systems.
His work has focused on translating complex physical and biological processes into controlled and reproducible systems.
He founded MicroDysis in 2003 based on core microfluidic technologies, following earlier work in medical device innovation and system development.
18+ USPTO and PCT patents, including one licensed to Agilent
Contributions to early EECP systems for cardiac therapy
Experience in advancing technologies from concept to commercialization
20+ years of continuous operation with multiple business awards
Development and Milestones
A progression from early research to integrated systems.
2003
Founded on patented microstructure fabrication and microsystem integration. This work was later recognized with the Thomas Alva Edison Patent Award (2009).
2005 – 2007
Development of a peristaltic micropump system, supported by New Jersey state seed funding. Contributed key patent and prototype development to Chrono Therapeutics, which later advanced to Series A and B financing. Recognized with the New Jersey SBDC Success Award (2006).
2007 – 2010
Development of a microarray-based system for molecular detection with enhanced sensitivity, supported by the New Jersey Edison R&D Fund and NIH/NCI SBIR funding.
Recognized with the New Jersey SBDC Success Award (2008).
2010 – 2011
Development of equipment for gradient gel plate manufacturing.
2012 – 2014
Development of microfluidic systems for picomole-scale oligonucleotide synthesis.
Reported in Tech Life Science Magazine (2013).
2014 – 2017
Development of a smart wearable system for controlled skin drug delivery
2018 – 2020
Development of a microfluidic in-vitro release testing (IVRT) autosampler for transdermal pharmaceutical applications.
2021 – Present
Development of microfluidic autostainer system for tissue staining and diagnostic workflows.
Explore Microfluidic Staining In Your Applications
From laboratory workflows to data-driven diagnostics